Metabolic study and controlled clinical trials of rifampin.
D000328:Adult; D000368:Aged; D000577:Amides / Q000627:therapeutic use; D000636:Aminosalicylic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D007539:Isonicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D012463:Saliva / Q000201:enzymology; D013307:Streptomycin / Q000008:administration & dosage / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use
D000577:Amides; D000636:Aminosalicylic Acids; D007539:Isonicotinic Acids; D013440:Sulfides; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin